KRAS biomarker testing disparities in colorectal cancer patients in New Mexico

INTRODUCTION: American Society of Clinical Oncology (ASCO) guidelines recommend that all patients with metastatic colorectal cancer (mCRC) receive KRAS testing to guide anti-EGFR monoclonal antibody treatment. The aim of this study was to assess for disparities in KRAS testing and mutational status....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Heliyon
Main Authors: Greenbaum, Alissa, Wiggins, Charles, Meisner, Angela LW, Rojo, Manuel, Kinney, Anita Y, Rajput, Ashwani
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5701808/
https://ncbi.nlm.nih.gov/pubmed/29202108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2017.e00448
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker